Selective β1-adrenoceptor agonist with positive inotropic activity. Prepn: M. Ikezaki et al., BE 833731; eidem, US 4032575 (1976, 1977 both to Tanabe Seiyaku); N. Umino et al., Chem. Pharm. Bull. 27, 1479 (1979). Effect on carbohydrate and lipid metabolism in rats: M. Inamasu et al., Biochem. Pharmacol. 33, 2171 (1984). Cardiovascular pharmacology in animals: T. Nagao et al., Jpn. J. Pharmacol. 35, 415 (1984); in humans: M. Kino et al., Am. J. Cardiol. 51, 802 (1983). Metabolism in humans: T. Suzuki et al., Drug Metab. Dispos. 11, 377 (1983). GC-MS determn in human urine: eidem, Chem. Pharm. Bull. 33, 2549 (1985). Binding affinity and selectivity: K. Naito et al., Jpn. J. Pharmacol. 38, 235 (1985). Clinical efficacy in congestive cardiomyopathy: J. Thormann et al., Am. Heart J. 110, 426 (1985). Series of articles on pharmacokinetics, metabolism and disposition in animals: Arzneim.-Forsch. 36, 643-667 (1986).
Cardiotonic.
β-Adrenergic Agonist; Cardiotonic